Take­da says farewell to CFO, suite of clin­i­cal-stage pro­grams in Q3 up­date

Take­da’s CFO is out, the com­pa­ny an­nounced Thurs­day along­side a se­ries of pipeline cuts.

Cos­ta Saroukos will step down on April 1 to move clos­er to his fam­i­ly in Aus­tralia, he said. He spent six years in the job and helped close one of the biggest deals in phar­ma his­to­ry — the $62 bil­lion Shire ac­qui­si­tion in 2019.

“Since then, he has been in­stru­men­tal in Take­da’s trans­for­ma­tion in­to a glob­al bio­phar­ma­ceu­ti­cal com­pa­ny and is hand­ing over an ex­cep­tion­al fi­nance or­ga­ni­za­tion,” CEO Christophe We­ber said on a call with in­vestors on Thurs­day as the com­pa­ny an­nounced its fis­cal third-quar­ter re­sults.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER